Table 2.
Subgroup analyses | Number of included studies | SMD [95% CI] | P value | Heterogeneity (I2, P value) | |
---|---|---|---|---|---|
Analyses based on studies only involving Type 2 diabetes patients | Overall analysis | 3 [19,24,25] | –0.34 [–0.50, –0.17] | <0.0001 | 28%, P=0.24 |
Post-intervention outcomes | 2 [24,25] | –0.53 [–0.82, –0.24] | 0.0004 | 46%, P=0.16 | |
Outcomes after 12 months follow up | 2 [19,25] | –0.43 [–0.81, –0.04] | 0.03 | 62%, P=0.07 | |
Analyses based on studies in which depression was evaluated using CES-D | Overall analysis | 3 [17–19] | –0.21 [–0.56, 0.13] | 0.23 | 52%, P=0.12 |
Post-intervention outcomes | 1 [18] | 0.02 [–0.45, 0.50] | 0.92 | - | |
Outcomes after 12 months follow up | 2 [17,19] | –0.32 [–0.81, 0.17] | 0.20 | 67%, P=0.08 |
-, no application.